找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunology; Cancer Immunotherapy Nima Rezaei Book 20151st edition Springer-Verlag Berlin Heidelberg 2015 Cancer immunology.Cancer im

[復(fù)制鏈接]
樓主: hierarchy
61#
發(fā)表于 2025-4-1 04:31:31 | 只看該作者
Immunopathology of Head and Neck Tumors and Immunotherapy of Squamous Cell Carcinoma,ce has been induced by cytotoxic T lymphocytes (CTLs), specific immune suppression is associated with tumor malignancy and progression. This contributes to unsatisfactory clinical outcome. In squamous cell carcinoma of the head and neck, the presence, activity, and also suppression of tumor-specific
62#
發(fā)表于 2025-4-1 07:16:33 | 只看該作者
Immunotherapy and Immunosurveillance of Oral Cancers: Perspectives of Plasma Medicine and Mistletoetime, a second tumor, located at the kidney, however remained unaffected. The main difference in treatment being peritumoral vs. systematic application supports the hypothesis of immunosurveillance. The impact of mistletoe extract in direct contact with the tumor tissue might be explained by targete
63#
發(fā)表于 2025-4-1 11:56:23 | 只看該作者
Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas, of the first forms of immunotherapy for the treatment of sarcoma. With advancements in molecular oncology and the identification of specific sarcoma antigens, direct experimentation has been made possible in a variety of preclinical animal models. Discoveries from the laboratory have led to novel i
64#
發(fā)表于 2025-4-1 16:18:23 | 只看該作者
65#
發(fā)表于 2025-4-1 19:52:33 | 只看該作者
Immunotherapy of Lung Tumors,nly in some countries. The recent campaigns aimed at cessation of smoking have dramatically reduced cardiovascular events in some European countries. However, lung cancer remains an elusive disease with not much improvement in overall survival despite neoadjuvant chemotherapy, making this tumor a di
66#
發(fā)表于 2025-4-1 23:57:44 | 只看該作者
67#
發(fā)表于 2025-4-2 03:42:13 | 只看該作者
68#
發(fā)表于 2025-4-2 08:05:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 06:59
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
龙山县| 开江县| 叶城县| 崇州市| 克拉玛依市| 普洱| 太谷县| 陵川县| 南汇区| 七台河市| 临汾市| 平果县| 上杭县| 金平| 凤阳县| 惠水县| 正蓝旗| 双峰县| 和平区| 三门峡市| 正蓝旗| 宁德市| 云梦县| 墨竹工卡县| 锡林浩特市| 盈江县| 鹿泉市| 佛教| 林西县| 泰兴市| 濮阳县| 宜川县| 新巴尔虎右旗| 乐昌市| 老河口市| 迁西县| 塔城市| 辽源市| 开鲁县| 玛多县| 九龙县|